Latest Period
n/a
Security Snapshot
INTEGRATED BIOPHARMA INC - COM (INBP) Institutional Ownership
CUSIP: 45811V105
13F Institutional Holders and Ownership History from Q4 2021 to Q3 2025
Institutions Reporting
Shares (Excl. Options)
Price
$0.29
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / COM
- Symbol
- INBP on OTC
- Price per share
- $0.29
- Price from insider filings
- $0.29
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- INBP - INTEGRATED BIOPHARMA INC - COM is tracked under CUSIP 45811V105.
- Latest finished 13F holder period is not available.
- Schedule 13D/13G significant owner rows are not currently available.
Change
- Holder count moved from 1 to 1 between Q2 2025 and Q3 2025.
- Reported value moved from $7,140 to $5,800.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC Evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
45811V105
Latest holder period
n/a
13F holders
13D/G owners
0
CIK / CUSIP context first
INBP full holder history
INTEGRATED BIOPHARMA INC SEC filings
INTEGRATED BIOPHARMA INC company facts
INTEGRATED BIOPHARMA INC insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 45811V105:
Institutional Holders of INTEGRATED BIOPHARMA INC - COM (INBP) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 20,000 | $5,800 | $0.29 | 1 | |
| 2025 Q2 | 20,000 | $7,140 | $0.36 | 1 | |
| 2025 Q1 | 20,000 | $5,600 | $0.28 | 1 | |
| 2024 Q4 | 20,000 | $5,800 | $0.29 | 1 | |
| 2024 Q3 | 20,000 | $4,688 | $0.23 | 1 | |
| 2024 Q2 | 20,000 | $4,200 | $0.21 | 1 | |
| 2024 Q1 | 20,000 | $3,852 | $0.19 | 1 | |
| 2023 Q4 | 20,000 | $4,902 | $0.25 | 1 | |
| 2023 Q3 | 20,000 | $5,600 | $0.28 | 1 | |
| 2023 Q2 | 20,000 | $6,600 | $0.33 | 1 | |
| 2023 Q1 | 20,000 | $7,660 | $0.38 | 1 | |
| 2022 Q4 | 20,000 | $7,038 | $0.35 | 1 | |
| 2022 Q3 | 20,000 | $9,000 | $0.45 | 1 | |
| 2022 Q2 | 20,000 | $10,000 | $0.50 | 1 | |
| 2022 Q1 | 20,000 | $16,000 | $0.80 | 1 | |
| 2021 Q4 | 20,000 | $19,000 | +$19,000 | $0.95 | 1 |